Computerworld Recognizes Dell for Support of Childhood Cancer Research
30 3월 2012 - 12:00AM
Business Wire
IDG’s Computerworld Honors Program has recognized Dell as a
2012 Laureate for its commitment of funding, employee engagement
and cloud computing technology in support of childhood cancer care
research globally. The annual award program honors visionary
applications of information technology promoting positive social,
economic and educational change.
Dell is being recognized in the “Emerging Technology” category
for providing the secure cloud-based IT infrastructure for the
world’s first personalized medicine trial for pediatric cancer
conducted by the Neuroblastoma and Medulloblastoma Translational
Research Consortium (NMTRC) and supported by The Translational
Genomics Research Institute (TGen).
The cloud platform provides needed computing power to help
increase TGen’s gene sequencing and analysis capacity by up to
1,200 percent and improve collaboration among the team working on
the trial.
Dell’s health giving program has expanded to support childhood
cancer care programs in other regions of the world, including
China, India, Malaysia, France, South Africa and Mexico. Learn more
about this initiative at www.dell.com/pediatriccancer.
The Computerworld Honors Program awards will be presented on
June 4 at a gala event in Washington, D.C.
Quotes
“There's no question technology plays a vital role in driving
business forward. It ensures an organization’s ability to
compete, innovate, communicate and thrive. What the
Computerworld Honors Laureates so clearly demonstrate is
technology’s role in moving society forward. Computerworld
acknowledges and applauds the outstanding work being done by
individuals and organizations who have successfully used technology
to improve the quality of our lives and that of future
generations,” said John Amato, vice president/publisher of
Computerworld. "Computerworld is proud to name the 2012 class
of Laureates and celebrate their initiatives benefiting society
through the innovative use of IT.”
“We believe that this personalized medicine trial can be a real
game-changer in the treatment of pediatric cancer, and this
recognition by Computerworld is a tribute to the good work being
done by TGen and NMTRC,” said James Coffin, Ph.D., vice
president and general manager of Dell Healthcare and Life
Sciences. “I’m proud that Dell solutions, people and funding
are addressing an unmet need and making a real and lasting
impact.”
About The Computerworld Honors Program
Founded by International Data Group (IDG) in 1988, The
Computerworld Honors Program is governed by the not-for-profit
Computerworld Information Technology Awards Foundation.
Computerworld Honors is the longest running global program to honor
individuals and organizations that use information technology to
promote positive social, economic and educational change.
Additional information about the program and a Global Archive of
past Laureate case studies, as well as oral histories of Leadership
Award recipients can be found at the Computerworld Honors
website.
About Dell
Dell Inc. (NASDAQ: DELL) listens to customers and delivers
innovative technology and services that give them the power to do
more. As the leading provider of healthcare IT services in the
world, Dell helps healthcare organizations harness the power of
information to simplify administration; coordinate and manage
patient care; transition from episodic care to prevention and
wellness management and ultimately to deliver personalized
medicine. For more information, visit www.dell.com/healthcare.
Dell is a trademark of Dell Inc. Dell disclaims any proprietary
interest in the marks and names of others.
Dell (NASDAQ:DELL)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Dell (NASDAQ:DELL)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024